The medical diagnostic code D64.9 refers to Anemia, unspecified
The exact product, concentration, route, and quantity should follow clinician directions
Each vial is supplied as a stable lyophilised powder and COA-verified to ensure purity, consistency, and reliability for controlled laboratory studies
Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults
Keep reading to find out more about compounded semaglutide and B12
Users who have achieved significant results may choose to continue at a maintenance dose, take a break and reassess, or adjust their protocol in consultation with a healthcare provider